Hospital
South Sunflower County Hospital
South Sunflower County Hospital was paid $8.23M by Medicaid between Jan 2018 and Dec 2024, across 119 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoSOUTH SUNFLOWER COUNTY HOSPITAL
INDIANOLA, MS 38751
INDIANOLA, MS 38751
33aNPI1184679292assigned 05/24/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.23M
24GClaims207,798
24DCodes billed119
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#39 of 77
Median peer was paid$8.23M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,768 | $1.27M | |
| 2019 | 34,640 | $1.37M | |
| 2020 | 28,993 | $1.09M | |
| 2021 | 29,758 | $1.20M | |
| 2022 | 34,792 | $1.25M | |
| 2023 | 29,823 | $1.21M | |
| 2024incomplete | 17,024 | $840K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 12,776 | 10,215 | $1.56M |
| G0378 | Hospital observation service, per hour | 13% | 3,172 | 1,580 | $1.08M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 5,540 | 4,046 | $871K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.5% | 3,701 | 2,871 | $701K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.2% | 15,056 | 2,307 | $426K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3.7% | 3,640 | 2,523 | $301K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.2% | 9,332 | 7,288 | $265K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.0% | 5,208 | 3,570 | $245K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.9% | 2,957 | 1,349 | $242K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.7% | 2,591 | 1,658 | $219K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.5% | 4,494 | 918 | $204K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 2,250 | 1,917 | $170K |
107 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.0% | 6,254 | $166K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.9% | 2,604 | $160K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 3,836 | $120K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.3% | 2,762 | $108K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 2,198 | $108K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 3,244 | $100K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 1,546 | $95K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 359 | $85K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 2,831 | $85K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,929 | $79K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,652 | $72K |
| 80053 | Comprehensive metabolic panel | <1% | 10,017 | $69K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 405 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,928 | $64K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 746 | $61K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,782 | $57K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,867 | $54K |
| 84484 | <1% | 3,137 | $22K | |
| 76801 | <1% | 290 | $21K | |
| 83880 | <1% | 957 | $20K | |
| 76818 | <1% | 281 | $19K | |
| 86900 | <1% | 338 | $19K | |
| 83874 | <1% | 2,726 | $18K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,229 | $17K |
| 59025 | Fetal non-stress test | <1% | 164 | $17K |
| 82553 | <1% | 2,702 | $16K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 12 | $16K |
| H0033 | Oral medication administration, direct observation | <1% | 7,131 | $16K |
| 87430 | <1% | 1,160 | $14K | |
| 97162 | <1% | 391 | $13K | |
| 81025 | <1% | 2,170 | $12K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 90 | $12K |
| 80305 | <1% | 1,810 | $12K | |
| 86756 | <1% | 756 | $9K | |
| 82948 | <1% | 2,827 | $8K | |
| 81001 | <1% | 4,410 | $7K | |
| 74018 | <1% | 160 | $7K | |
| 86738 | <1% | 712 | $7K | |
| 81000 | <1% | 3,125 | $6K | |
| 86901 | <1% | 376 | $6K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 87 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 112 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 45 | $6K |
| 97016 | <1% | 632 | $5K | |
| 86850 | <1% | 152 | $5K | |
| 97014 | <1% | 976 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 501 | $5K |
| 87088 | <1% | 973 | $4K | |
| 73630 | <1% | 122 | $3K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 347 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,261 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 278 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 58 | $3K |
| 83690 | <1% | 644 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,327 | $2K |
| 87040 | <1% | 295 | $2K | |
| 81015 | <1% | 1,309 | $2K | |
| 83735 | <1% | 451 | $2K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | <1% | 14 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,353 | $2K |
| 73030 | <1% | 12 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,765 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 313 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,248 | $1K |
| 36600 | <1% | 39 | $1K | |
| 82150 | <1% | 300 | $1K | |
| 85379 | <1% | 156 | $834.58 | |
| 74019 | <1% | 14 | $813.53 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 2,333 | $738.20 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 30 | $638.40 |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | <1% | 188 | $633.83 |
| 73560 | <1% | 19 | $604.56 | |
| 82077 | <1% | 52 | $567.91 | |
| 87077 | <1% | 82 | $523.38 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 98 | $458.95 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 993 | $438.98 |
| 86140 | <1% | 130 | $339.27 | |
| 71250 | <1% | 18 | $334.41 | |
| 82803 | <1% | 38 | $268.84 | |
| 85027 | <1% | 49 | $266.63 | |
| 85610 | <1% | 110 | $255.44 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $254.84 |
| 87184 | <1% | 44 | $232.32 | |
| 80306 | <1% | 17 | $185.16 | |
| 85730 | <1% | 34 | $131.34 | |
| Q3014 | Telehealth originating site facility fee | <1% | 24 | $119.96 |
| 87070 | <1% | 12 | $77.49 | |
| 94664 | <1% | 1,374 | $57.24 | |
| 84550 | <1% | 14 | $54.24 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 67 | $52.80 |
| 87205 | <1% | 15 | $51.36 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 31 | $12.65 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,255 | $1.65 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 264 | $0.00 |
| 91301 | 0% | 329 | $0.00 | |
| 96376 | 0% | 511 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 115 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 44 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 61 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 82 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 33 | $0.00 |
| 94760 | 0% | 21 | $0.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 286 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 71 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 462 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 40 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPHILLIPS, COURTNEY (ADMINISTRATOR)